Is sacubitril/valsartan safe for treatment of hypertension at any age?

J Cardiovasc Med (Hagerstown). 2019 Jan;20(1):49. doi: 10.2459/JCM.0000000000000728.
No abstract available

Publication types

  • Letter

MeSH terms

  • Age Factors
  • Aminobutyrates / adverse effects
  • Aminobutyrates / therapeutic use*
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use*
  • Biphenyl Compounds
  • Blood Pressure / drug effects*
  • Clinical Decision-Making
  • Drug Combinations
  • Female
  • Humans
  • Hypertension / diagnosis
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • Male
  • Middle Aged
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Risk Factors
  • Tetrazoles / adverse effects
  • Tetrazoles / therapeutic use*
  • Treatment Outcome
  • Valsartan

Substances

  • Aminobutyrates
  • Antihypertensive Agents
  • Biphenyl Compounds
  • Drug Combinations
  • Tetrazoles
  • Valsartan
  • sacubitril and valsartan sodium hydrate drug combination